Ventrus Biosciences Cash and ST Investments:
20.49M for Dec. 31, 2012Ventrus Biosciences Historical Cash and ST Investments Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 20.49M |
| Sept. 30, 2012 | 23.56M |
| June 30, 2012 | 28.84M |
| March 31, 2012 | 31.07M |
| Dec. 31, 2011 | 36.98M |
| Sept. 30, 2011 | 53.29M |
| June 30, 2011 | 11.37M |
| March 31, 2011 | 14.00M |
| Dec. 31, 2010 | 14.57M |
| Sept. 30, 2010 | 0.2711M |
| June 30, 2010 | 0.6497M |
| March 31, 2010 | 1.068M |
| Dec. 31, 2009 | 0.0813M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and short term investments are considered very liquid assets. For instance, if a company needs immediate liquidity, cash and short term investments can be be quickly used. Cash and short term investments are frequently used in liquidity ratios.
Learn More
VTUS Cash and ST Investments Benchmarks
| Companies | |
|---|---|
| GlaxoSmithKline | 5.950B |
| Tetraphase Pharmaceuticals | 9.079M |
| Zoetis | 317.00M |
VTUS Cash and ST Investments Rankings
| Overall |
60th percentile 3001 of 7593 |
| Sector |
41st percentile 380 of 650 in Healthcare |
| Industry |
57th percentile 22 of 52 in Drug Manufacturers - Major |
VTUS Cash and ST Investments Range, Past 5 Years
| Minimum | 0.0813M | Dec 2009 |
| Maximum | 53.29M | Sep 2011 |
| Average | 18.17M |
